Boehringer and Lilly’s CAROLINA cardiovascular outcome trial for Trajenta meets primary endpoint of non-inferiority compared to glimepiride Read more
Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate Read more
Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials Read more
Novartis receives FDA approval for Egaten for the treatment of fascioliasis, a neglected tropical disease Read more
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe Read more
Hear exclusive insights from leading microbiologists at SMi’s Pharmaceutical Microbiology East Coast Event Read more
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States Read more